Alterations in Wnt-β -catenin and Pten signalling play distinct roles in endometrial cancer initiation and progression-Reference-Cited by-同舟云学术

Alterations in Wnt-β -catenin and Pten signalling play distinct roles in endometrial cancer initiation and progression

Published:2013-03-14 Issue:1 Volume:230 Page:48-58
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

van der Zee Marten¹²,Jia Yundan¹²,Wang Yongyi¹²,Heijmans-Antonissen Claudia¹,Ewing Patricia C²,Franken Patrick²,DeMayo Francesco J³,Lydon John P³,Burger Curt W¹,Fodde Riccardo²,Blok Leen J¹

Affiliation:

1. Department of Obstetrics and Gynaecology; Erasmus MC University Medical Centre; Rotterdam The Netherlands

2. Department of Pathology; Erasmus MC University Medical Centre; Rotterdam The Netherlands

3. Department of Molecular and Cellular Biology; Baylor College of Medicine; Houston TX USA

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.4160/fullpdf

Reference39 articles.

1. APC, β-catenin, and E-cadherin and the development of recurrent endometrial carcinoma;Pijnenborg;Int J Gynecol Cancer,2004

2. Germline PTEN mutations as a cause of early-onset endometrial cancer;Blumenthal;J Clin Oncol,2008

3. p53 gene mutations in human endometrial carcinoma;Risinger;Mol Carcinog,1992

4. Abnormalities of the APC/β-catenin pathway in endometrial cancer;Moreno-Bueno;Oncogene,2002

5. Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype;Zysman;Cancer Res,2002

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diverse roles of UBE2S in cancer and therapy resistance: Biological functions and mechanisms;Heliyon;2024-01

2. Developmental estrogen exposure in mice disrupts uterine epithelial cell differentiation and causes adenocarcinoma via Wnt/β-catenin and PI3K/AKT signaling;PLOS Biology;2023-10-19

3. Role of non‑coding RNA intertwined with the Wnt/β‑catenin signaling pathway in endometrial cancer (Review);Molecular Medicine Reports;2023-06-20

4. Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy inCTNNB1-mutated endometrial cancer;2023-04-06

5. The Role of WNT Pathway Mutations in Cancer Development and an Overview of Therapeutic Options;Cells;2023-03-24